Qube Research & Technologies LTD Organon & Co. Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$10.95 - $17.32 $13.7 Million - $21.7 Million	1,254,374 Added 707.0%	1,431,795 $20.6 Million
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $2.94 Million - $4.22 Million	177,421 New	177,421 $3.08 Million
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $11.4 Million - $16.7 Million	487,076 Added 670.77%	559,690 $13.1 Million
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $250,430 - $307,699	7,910 Added 12.22%	72,614 $2.45 Million
Q1 2022 May 09, 2022	SELL	$30.45 - $39.36 $3.92 Million - $5.06 Million	-128,630 Reduced 66.53%	64,704 $2.26 Million
Q4 2021 Feb 01, 2022	BUY	$28.67 - $37.13 $4.92 Million - $6.38 Million	171,721 Added 794.53%	193,334 $5.89 Million
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $211,489 - $263,272	-7,387 Reduced 25.47%	21,613 $709,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $825,050 - $1.1 Million	29,000 New	29,000 $878,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.